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Background: Many countries have over the last few years incorporated mental health assertive interventions in an
attempt to address the repercussions of deinstitutionalization. Recent publications have failed to duplicate the positive
outcomes reported initially which has cast doubt on the future of these interventions. We previously reported on 29
patients from a developing country who completed 12 months in an assertive intervention which was a modified
version of the international assertive community treatment model. We demonstrated reduction in readmission rates as
well as improvements in social functioning compared to patients from the control group. The obvious question was,
however, if these outcomes could be sustained for longer periods of time. This study aims to determine if modified
assertive interventions in an under-resourced setting can successfully maintain reductions in hospitalizations.
Methods: Patients suffering from schizophrenia who met a modified version of Weidens’ high frequency criteria were
randomized into two groups. One group received a modified assertive intervention based on the international assertive
community treatment model. The other group received standard care according to the model of service delivery in this
region. Data was collected after 36 months, comparing readmissions and days spent in hospital.
Results: The results demonstrated significant differences between the groups. Patients in the intervention group had
significantly less readmissions (p = 0.007) and spent less days in hospital compared to the patients in the control group
(p = 0.013).
Conclusion: Modified assertive interventions may be successful in reducing readmissions and days spent in hospital in
developing countries where standard care services are less comprehensive. These interventions can be tailored in such
a way to meet service needs and still remain affordable and feasible within the context of an under-resourced setting.
Keywords: Assertive interventions, Developing countries, Readmission rates, Days in hospitalBackground
Assertive Community Treatment (ACT) is by now a well-
known approach that has been adopted in many countries
[1-3]. Initially, one of the most attractive motivators for
the incorporation of this approach in mental health service
delivery, was its apparent success in reducing readmis-
sion rates in so-called revolving door patients. Though
considered an expensive intervention, the costs were* Correspondence: ullabotha@gmail.com
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reproduction in any medium, provided the orjustified under the premise that inpatient costs were
generally much higher. The approach has been well
researched and tested over the last twenty years, with
many countries reporting on a range of outcomes, such
as readmission rates, patient satisfaction, degrees of
symptomatology and social functioning [4-6,3,2,7]. Initial
studies from particularly the US and Australia, reported
positive outcomes in most of these areas, which prompted
UK decision makers to launch 300 Assertive Outreach
teams nationwide [1-3]. Though some UK studies initially
demonstrated favourable outcomes, few studies reported
reduction in readmission rates. A number of recent UKtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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tions compared with the CMHT control groups and have
concluded that the approach may no longer be justifiable,
considering the cost [1,8]. The discrepancy in findings
by different research groups and countries has created
considerable controversy [1,9,10].
Burns et al. performed a meta-regression with 64 trials
in an attempt to identify factors that may contribute to
outcomes. They found that a high baseline “days in
hospital” (DIH) was often associated with higher reduc-
tion and that teams with high fidelity to the ACT
model, also appeared to have lower readmission rates.
One of the common criticisms has been that control
groups have been poorly defined [1]. Clearly, “standard
care” or “treatment as usual” is quite non-specific, as
standard care services vary considerably within countries
and even more so between countries. Several of the stud-
ies that demonstrated no significant improved outcomes,
reported that the standard care services appeared to have
incorporated many of the salient features of the ACT
approach, such as fixed caseloads (though larger than
those in ACT), home visits and assertive follow-up
[11,12]. One study even reported a standard care service
with a higher fidelity score than the ACT group it was
being compared with [13].
Despite the apparent downfall of the ACT approach in
the UK, it is still being employed with success in other
countries. A recent German study in Hamburg demon-
strated reduced inpatient days in patients followed-up
assertively for 12 months and concluded that the inter-
vention was more cost-effective than the standard care
service it was compared with. Though outpatient costs
had been higher in the intervention group, the total
cost was still lower due to the significantly more expensive
inpatient costs [6]. Similarly, a recent Danish study dem-
onstrated patients receiving an assertive intervention
for two years, had less substance use, better adherence
to medication and were more satisfied with their treat-
ment. In addition to this, they also reported significantly
lower usage of inpatient services compared to the control
group [5].
Developing countries face the same challenges of re-
volving door patients and bed pressures, but have the
additional burden of limited resources and lack of
funding to contend with. Hanlon et al. reported that
only 56.5% of African countries have community-based
mental health services and only 50% have existing mental
health policies [14]. One of the important recommenda-
tions from this publication was the need for strengthening
of specialist mental health services and further integration
of mental health service with primary health service. Patel
et al. called for scaling up of cost-effective community
based mental-health services in middle and low-income
countries citing successes in countries such as India, Chileand China, where interventions had been modified to
meet the resources and needs of the community [15].
Odenwald et al. reported on such an intervention in
Somalia, which offered a 10 month programme to a group
of 35 outpatients with chronic psychotic disorders. The
intervention was a home-based programme which incor-
porated psycho-education, relapse prevention and family
support and was found to be cost-effective and feasible in
a low-income country [16].
In South-Africa, similar attempts have been made to
address the challenges in finding a cost-effective commu-
nity-based initiative. As part of a provincial initiative,
the Western Cape Province launched three Assertive
Community Treatment (ACT) teams in 2007. The teams
followed a modified version of the ACT model, par-
ticularly in terms of case loads and visit frequency. We
reported that at the one year follow-up the patients
who completed the intervention demonstrated significant
reduction in days spent in hospital and improvements in
social functioning in comparison to patients receiving
the standard care service package. Though the follow-up
period was only 12 months, these were the first indicators
that assertive interventions could be successfully modified
to meet the needs of under-resources areas without
compromising the efficacy of the intervention [17]. This
supports past comments by international authors [1,18]
that assertive interventions may be more effective in
under-resourced areas where standard care services are
less comprehensive.
The important question, however, remains whether
positive outcomes can be sustained over time. It is well-
known that newly established services may initially have
good outcomes due to staff enthusiasm and initial smaller
caseloads, but that these outcomes often tail off over time
as burn-out ensues and pressure rises [11].
Aim
The purpose of this study was to determine if modified
assertive interventions in an under-resourced setting can
successfully maintain reductions in hospitalizations over
a 36 month follow-up period.
Methods
This study was conducted in Stikland Hospital, one of
the three large state mental health hospitals in Cape
Town, South Africa. The hospital, along with two others,
provides inpatient services to the whole of the Western
Cape Province covering a population of approximately
5 million people. The combined bed capacity for acute
psychotic patients in the three hospitals is 500. The
Stikland Hospital ACT team initially consisted of a full-
time psychiatrist, a social worker and a chief professional
nurse, but has been expanded over time. Currently the
team consists of a medical officer, a social worker, three
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has access to an occupational therapist, a dual diagnosis
service and a PSR-based day program.
All subjects who presented for admission over an
eighteen month period and who had a previously estab-
lished, documented diagnosis of schizophrenia or schizo-
affective disorder (DSM-IV-TR) were eligible for inclusion.
To be included as high frequency users (HFUs), subjects
had to fulfil the inclusion criteria, which was modified
from Weiden’s HFU-criteria (see List of criteria below) to
accommodate local admission patterns and ensure the
appropriate service users were targeted [19]. Subjects
were excluded if they had (1) a serious, unstable co-morbid
medical illness that could interfere with their ability to
participate in the intervention; (2) were unable to give
written informed consent or (3) if another co-morbid
Axis I or II diagnosis other than schizophrenia or schizo-
affective disorder was the current focus of treatment.
List of criteria: Modified Weidien’s criteria for differ-
entiation high frequency (HFU) and low frequency
(LFU) schizophrenia-spectrum disorder users of psy-
chiatric services:
General criteria
1) Schizophrenia or Schizo-affective Disorder
2 Age 18–59 years (extremes included)
3 Needs current treatment with antipsychotic
Must meet General Criteria PLUS either (A) or (B) or
(C) to be included
(A)≥3 admissions in 18 months/≥ 5 in 36 months
(B) ≥2 admissions in 12 months AND treated with
clozapine
(C)≥2 admissions in 12 months AND ≥120 days in
hospital
HFUs had to fulfill General Criteria PLUS one of A; B or.
The study was approved by the research ethics commit-
tees of both the Universities of Stellenbosch and Cape
Town. The research component constituted approxi-
mately half of the caseload of the ACT team whereas a
non-research component provided the same intervention
to high frequency users (HFUs) with other diagnoses. Re-
search numbers therefore do not reflect overall caseloads.
The trial took the form of a randomized, non-blinded
parallel group study. Subjects (n = 65) identified as HFUs
who provided informed, written consent, were considered
for inclusion. Randomization was done using standardized
tables, patients were allocated to one of two treatment
groups (See Figure 1).
Subjects from both groups, a) treatment as usual (n = 26)
and b) Intervention group (n = 34), received visits at
inclusion, prior to discharge and after 12 months. At
36 month follow-up, data was collected from patient
folders or from patients directly where no readmissionshad been documented. The same method was used for
both groups to obtain readmission information. Admis-
sions data is easily accessible on the provincial data
systems and also indicates admissions to other hospitals in
the province. Where no readmissions were documented,
patients or families were contacted to rule out any out
of area admissions or adverse events. Where patients or
families could not be reached, the community mental
health practitioner was contacted to obtain information.
Information was collected about number of readmissions,
number of days spent in hospital at each admission,
months in service (control or intervention respectively),
number of days until first admission, number of admissions
to intermediate care facility, adverse events and demo-
graphics were confirmed. Data was collected over a 72
month period; 36 months prior to date of inclusion (pre-
DOI) and 36 months post -date of inclusion (post-DOI).
Subjects from the treatment as usual group were dis-
charged into the existing standard care system. At 36
month follow-up data was collected from subject files
and directly from subjects where files did not provide
sufficient information.
Subjects from the intervention group were each
assigned a key worker in the form of a senior social
worker or a chief professional nurse. Key workers started
engaging subjects and carers prior to discharge with the
primary focus on building a therapeutic relationship.
The nature of the intervention was tailored as close as
possible to the international model of assertive commu-
nity treatment, with the two main exceptions in the size
of caseloads and frequency of visits. It was agreed at the
onset that the caseloads carried by international teams
would not be realistic in the context of a pressured system
in an under-resourced developing country. A consensus
of 80 patients per team was reached, with individual
caseloads not exceeding 35. Fidelity to the international
model was assessed with the Dartmouth Assertive Com-
munity Treatment Scale (DACTS) with a total score of 3.1
[20]. Key workers acted as main care coordinators but
caseloads were often shared between members of the
team. A major focus in the team was on engagement
and maintaining compliance on medication. The team
also attempted to make use of existing resources in the
community in addition to the service provided by the
team. This may be considered a minor deviation from
the ACT model where care is coordinated solely by the
ACT team, but may be a practical option where teams
need to spread themselves thinly. Frequency of patient
contacts was individualized according to patient need
with minimum of fortnightly contacts by any member
of the team. Patients had access to occupational therapy
and psychology services although no full-time staff was
available from these disciplines. The majority of contacts
(>50%) were in the community, mainly home visits.
Figure 1 Flow diagram describing allocation of patients.
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three state mental hospitals in the Western Cape. This
had both advantages and disadvantages since the team
was able to draw from the various resources in the hospital
setting to strengthen the service it provided, such as access
to a day programme offering psycho-social rehabilitation.
The team also acted as bridge between hospital-based care
and community mental health services, offering valuable
liaison and streamlining communication between services.
Readmissions were treated like adverse events; the team
would liaise with inpatient staff and commence follow-up
of patient upon discharge without any change to the
follow-up period. Incarcerations were not considered in
the same manner as admissions, since incarceration does
not necessarily imply that appropriate psychiatric care is
given. One intervention patient was incarcerated during
the 36 month period but the team continued to performvisits in prison. One patient from the control group had
been incarcerated during the 36 month period.
Patients in this catchment area have access to an inter-
mediate rehabilitation facility. This unit functions as a
step-up/step-down facility and offers a psycho-social
rehabilitation (PSR) program. Data was collected separately
on the number of patients who attended this program
since this may impact on readmission rates. Patients from
both groups had access to the facility but these admissions
were not considered in the same way as admissions to the
acute wards.
At 12 month follow-up, additional information was
collected about readmissions and any changes in medi-
cation. Patients in the intervention group remained in
the service and those in the control group were given
the option to be included in the intervention group.
Subsequently, two patients from the control group were
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month follow-up period. There was no official drop-out
policy and none of the intervention patients dropped out
during the first 12 months of the study. Two patients from
the intervention group were discharged after 14 and 16
months of follow-up respectively. In both instances
patients had been following up in the community for
longer than six months without concerns about com-
pliance or indications of relapse. Both patients had
been well integrated with their respective community
services and appeared no longer to require assertive
input. One patient died after two months in the study.
Time to readmission for this person was censored at time
of death. Four patients who signed informed consent
initially were referred to long-term wards (See Figure 1).
Patients who were referred to long-term wards prior to
their index visit were excluded. Patients who were re-
admitted and referred to long-term wards after a period
of follow-up, were not excluded and DIH were included
for analysis. Both groups were considered in the same
way. Service contacts were not measured for the control
group. The spectrum of standard care is very diverse and
contacts are often infrequent, depending on which
particular community service patients made use of.
(See Table 1 for comparisons of care received between
the two groups).Statistical analysis
Data was summarised through counts (n) and frequencies
(%), medians and interquartile ranges (IQR) or means and
standard deviations (sd). Wilcoxon Mann–Whitney Rank
Sum tests (non-parametric) were used to test median
differences while the T-test was used to test differences
in means for normally distributed data. Fisher tests of
association were used for count data.Table 1 Work style of modified ACT team compared to stand
Modified ACT team
Overall patient load 80-100 patients
Individual caseload Maximum 35
Workstyle Key workers act as care coordinator but caseload
Site of most visits >50% contacts are home visits
Engagement Assertive; focus on engagement, immediate resp
non-compliance
Working hours Office hours
24 hour cover Patients referred to hospital-based after-hours se
coordinated by ACT when in crisis.
Frequency of contacts Individualized according to patient need at least
Disciplines available Full-time psychiatrist, social worker, Psychiatric nu
psychologist, occupational therapist, dual diagnoTime to readmission was considered as the number of
days to first admission after discharge, and was used as
the outcome variable in the Survival analyses methods
employed. Patients who completed a 36 month follow-up
without readmissions were “censored” since their readmis-
sion history is not known beyond the end of the study.
For Kaplan-Meier methods, data was assumed to be
right-censored. To statistically test whether or not there is
a difference in time to readmission between the cases
and controls, and to test for covariates in the model, a
Cox proportional hazards regression was carried out.
The Cox regression model is a non-parametric model
which assumes that the hazard rate is proportional. This
assumption was tested graphically and using goodness-
of-fit tests and found to be valid. Hazard ratios were
calculated from the results of the regression. Since the
effect of group membership on readmission was of
interest, separate curves were produced so that they
could be compared graphically. All statistical analyses
were carried out using the package R: A Language for
Data Analysis and Graphics [21].Results
Data were analyzed for 32 patients in the (cases) inter-
vention group and 24 patients in the control group. The
baseline demographics from both groups confirmed the
homogeneity of the group for all demographic variables,
except place of residence (Fisher’s test p-value = 0.01), at
a 5% level of significance (Table 2). There was no missing
data; all patients were successfully located at 36 month
follow-up. The median age of the control group was 27.5
Years (IQR = (23.8, 36.8) years) and that for the cases
was 32.0 years (IQR = (26.8, 42.8) years). To test this
difference, the nonparametric Wilcoxon Mann–Whitney
Rank Sum test was used and showed the difference wasard care
Community mental health team
± 600 patients excluding assessments of new patients
250
s are shared Individual caseloads
Office based
onse to Non-assertive, no follow-up of missed appointments/
reports of non-compliance
Office hours
rvice After-hours service of catchment area.
fortnightly Depends on caseloads, varies between monthly to
three monthly.
rse, access to
sis service.
Full-time psychiatric nurse, access to social worker
and psychiatrist, varied access to occupational therapist
and psychologist.
Table 2 Demographic differences between cases and controls
Cases Controls Total
Gender Male 22 (69) 19 (79) 41 (73)
Female 10 (31) 5 (21) 15 (27)
Total: 32 (100) 24 (100) 56 (100)
Ethnicity Caucasian 1 (3) 0 (0) 1 (2)
Coloured 30 (94) 21 (88) 51 (91)
Xhosa 1 (3) 3 (13) 4 (7)
Total: 32 (100) 24 (100) 56 (100)
Marital status Single 27 (84) 18 (75) 45 (80)
Married 3 (9) 2 (8) 5 (9)
Divorced 2 (6) 4 (17) 6 (11)
Total: 32 (100) 24 (25) 56 (100)
Language Afrikaans 29 (94) 21 (88) 50 (91)
English 1 (3) 0 (0) 1 (2)
Xhosa 1 (3) 3 (13) 4 (7)
Total: 31 (100) 24 (100) 55 (100)
Employment Unemployed 31 (97) 24 (100) 55 (98)
Casual 1 (3) 0 (0) 1 (2)
Total: 32 (100) 24 (100) 56 (100)
Residence** Metro 32 (100) 19 (79) 51 (91)
Rural 0 (0) 5 (21) 5 (9)
Total: 32 (100) 24 (100) 56 (100)
Accommodation Family 32 (100) 24 (100) 56 (100)
Total: 32 (100) 24 (100) 56 (100)
Highest Level of Education Elementary 14 (44) 5 (21) 19 (34)
Secondary 14 (44) 14 (58) 28 (50)
Matric 4 (13) 4 (17) 8 (14)
None 0 (0) 1 (4) 1 (2)
Total: 32 (100) 24 (100) 56 (100)
Adverse events None 30 (94) 24 (100) 54 (96)
Pregnancy 1 (3) 0 (0) 1 (2)
Death 1 (3) 0 (0) 1 (2)
Total: 32 (100) 24 (100) 56 (100)
Status changes No change 27 (84) 20 (83) 47 (84)
Discharge from Intervention 2 (6) 0 (0) 2 (4)
Included in Intervention 2 (6) 4 (17) 6 (11)
Death 1 (3) 0 (0) 1 (2)
Total: 32 (100) 24 (100) 56 (100)
Disability grant Yes 28 (88) 22 (92) 50 (89)
No 4 (13) 2 (8) 6 (11)
Total: 32 (100) 24 (100) 56 (100)
**Significant difference detected (Fisher’s test: p-value = 0.01).
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for comparisons between the two groups with regards to
days spent in hospital (DIH) and number of admissionspre-and-post inclusion. When comparing days spent in
hospital in the 36 months prior to inclusion (pre-DOI)
in this study (Table 3), no significant difference was
Table 3 Summary - days in hospital and number of admissions, for each group
Cases n = 32; controls n = 24 Mean (SD) % of n with admissions
Days in hospital
Pre-date of inclusion Cases 264.8 (108.0) 100%
Controls 261.5 169.8) 100%
Post-date of inclusion Cases 35.2 (64.4) 40.60%
Controls 51.5 (219.2) 75%
Pre-Post date of inclusion Cases 229.7 (130.2)
Controls 110 (187.6)
Median (IQR) Wilcoxon test
Estimate (Cl) p-value
Pre-date of inclusion Cases 256.0 (174.2, 319.2) 27 (−38, 92) 0.376
Controls 202.0 (152.8, 311.5)
Post-date of inclusion Cases 0.0 (0.0, 52.0) −53 (−96, −6) 0.002
Controls 88.0 (6.8, 161.2)
Pre-Post date of inclusion Cases 230.0 (147.8, 314.8) 93 (24, 177) 0.013
Controls 130.0 (57.8, 235.0)
Cases n = 32; controls n = 24 Mean (SD)
Number of admissions
Pre-date of inclusion Cases 4 (1.8)
Controls 4 (1.5)
Post-date of inclusion Cases 1.5 (0.8)
Controls 2 (1.3)
Pre-Post date of inclusion Cases 4 (2)
Controls 2 (1.8)
Median (IQR) Wilcoxon test
Estimate (Cl) p-value
Pre-date of inclusion Cases 4.0 (3.0, 5.0) 0 (0, 1) 0.515
Controls 3.0 (3.0, 4.0)
Post-date of inclusion Cases 0.0 (0.0, 1.0) −1 (−2, 0) 0.001
Controls 2.0 (0.8, 2.3)
*Pre-Post date of inclusion Cases 3.56 (2.0) 1.4 (0.4, 2.5) 0.007
Controls 2.13 (1.8)
*Summarised using mean (sd).
Botha et al. BMC Psychiatry 2014, 14:56 Page 7 of 10
http://www.biomedcentral.com/1471-244X/14/56found between the two groups (p-value = 0.376). For
the post date of inclusion data (post-DOI), there was a
significant difference between the cases and controls
(p-value = 0.002). To compare the pre and post-DOI
data of the two groups, the difference was calculated as
pre-DOI minus post-DOI number of days in hospital
for each group separately. A Wilcoxon Mann–Whitney
rank sum test on this data yielded a p-value of 0.013,
indicating a significant difference between the two groups.
However, the large confidence interval (CI = (24,177))
indicates lack of precision in the estimation, which is
likely due to a patient in the control group with a long
length of stay post-DOI. The Wilcoxon test was re-
peated without this patient and yielded a p-value of0.023 (CI = (15, 163)). Thus, one can still conclude that
there is a statistically significant difference between the
pre-minus post-DOI days in hospital between the two
groups.
Table 3 also summarizes the number of readmissions
for each group. The difference between the groups is again
demonstrated using pre-DOI number of admissions
minus post-DOI number of admissions. This data was
normally distributed thus a t-test was used to demonstrate
a difference in the means. It gave a p-value of 0.007, which
indicates a significant difference in the mean pre-minus
post-DOI admissions between cases and controls.
There was no significant difference between the two
groups in terms of admissions to the intermediate
Table 5 Estimated hazard ratios from a Cox
regression model
Hazard ratio (95% CI)
Group 2.43 (1.06, 5.57)
Gender 1.15 (0.46, 2.84)
Age 0.98 (0.94, 1.03)
Days in hospital pre-DOI 1.00 (1.00, 1.00)
Number of admissions pre-DOI 1.02 (0.77, 1.35)
t r
ea
dm
itt
ed
0.
6
0.
8
1.
0
Botha et al. BMC Psychiatry 2014, 14:56 Page 8 of 10
http://www.biomedcentral.com/1471-244X/14/56rehabilitation facility (Fisher test p-value = 0.543). Of
note was that though the number of admissions was
the similar (n = 5 for controls, n = 6 for cases) in both
groups, the intervention group had two patients with
more than one admission to the facility, whereas all pa-
tients admitted from the control group had single admis-
sions to the facility (See Table 4).
To compare the readmission experience of cases and
controls, Kaplan-Meier (K-M) Survivor Curves were plot-
ted separately for each group (not shown). Two patients
were censored; one patient died two months into the
study (case) and another was included much later than
other patients (control). The K-M plot clearly demon-
strated that in the first 200 days there was little difference
between the two group but after 200 days, the controls
were more likely to be readmitted. The curves also moved
further apart over time, indicating that the intervention
became more beneficial over time. The K-M curves do not
provide statistical evidence of a significant difference. To
demonstrate this, the log-rank test was applied and
gave a p-value of 0.027, which demonstrated a statistically
significant difference between the readmission rates of the
two groups. However, we cannot adjust for covariates
using a log-rank test so a Cox Proportional Hazards model
was carried out where age, gender, number of admissions
pre-DOI and days in hospital pre-DOI were all adjusted
for (Table 5). After adjusting for these factors, the model
gave a hazard ratio of 3.0 (CI = (1.4, 6.7)), indicating a
significant difference between admission experience of the
cases and controls. A hazard ratio of 3.0 indicates that
being in the control increases your hazard of readmission
three-fold, on average. Figure 2 shows a plot of this model
with separate curves for the cases and controls. Censored
patients are represented by the crosses on the curves.
Discussion
Reductions in readmission rates are widely accepted to
be an effective way to assess outcome of assertive inter-
ventions and are often used as primary outcome [3].
One criticism against this method has been that this
outcome may have large appeal to managers due to cost-
implications and may not necessarily reflect a positiveTable 4 Summary of admissions to intermediate
rehabilitation facility
Cases Controls Total
Number of admissions
to rehab facility
n (%) n (%) n (%)
0 27 (84) 19 (79) 46 (82)
1 3 (9) 5 (21) 8 (14)
2 1 (3) 0 (0) 1 (2)
3 1 (3) 0 (0) 1 (2)
Total 32 (100) 24 (100) 56 (100)outcome for patients. However, combining this outcome
with length of stay (and measurements in degrees of psy-
chopathology) provide the necessary reassurances that
the outcomes are not simply being produced by denying
patients access to necessary care, but that the intervention
actually reduces the need for admission [1,3,17].
The results indicate that the reduction in inpatient
days that has been previously reported on, can indeed be
sustained in the long run. This was considered one of
the limitations of the original 12 month follow-up, since
there are several factors that may contribute to short-
term outcomes [17]. Both Sytema and Killaspy reported
on the fact the newly established teams may initially
produce positive outcomes that could tail off over time
[8,11]. Newly established teams often start off with high
staff enthusiasm and pressure to succeed and depending
on the recruitment style, initial caseloads may be smaller
than anticipated. Once caseloads increase and the novelty
of the approach wears off, staff may have less time for as
frequent and comprehensive input and could possibly be
less likely to “go the extra mile”, so to speak. Also, since
most patients were included in the service directly after anTime to first readmission (days)
Pr
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or
tio
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Control
Hazard ratio=3.0
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Figure 2 Survival curves for cases and controls from a Cox
proportional hazards model.
Botha et al. BMC Psychiatry 2014, 14:56 Page 9 of 10
http://www.biomedcentral.com/1471-244X/14/56admission, one may speculate that this would reduce the
number of readmissions in 12 months in itself. In addition
to this, global pressures on inpatient beds mean that
patients generally have to be quite ill in order to warrant
admission, which in turn means that patients who are
not behaviourally disturbed and pose less of a risk, may
be managed in the community. These factors necessitate
the use of a control group to adequately assess the effect-
iveness of such an intervention.
Demonstrating sustained reduction in readmissions over
a 36 month period, means that the “new team” factor is
less likely to contribute. By 18 months, all key workers
were managing case loads of approximately 30 patients or
more. In addition to this, one may speculate that having
successfully demonstrated significantly reduced days in
hospital, the team may have felt less pressured to sustain
the level of input that had been given thus far. Surely, if
“new team” enthusiasm and pressure to succeed may
contribute to a teams’ ability to produce positive outcomes,
the lack thereof may be expected to have the opposite
effect. This was not the case however, despite the team
experiencing other typical phenomenon described by
established teams, such as staff-burn-out.
Days to first admission reflects the number of days
from initial inclusion to first readmission. This does not
necessarily reflect how stable the patients were during this
time. Previous publications by our group have demon-
strated higher degrees of symptomatology in the control
group [17]. Clinical experience has shown that patients
followed-up in a standard care setting, are seen less
frequently by mental health practitioners and are often
left to cope with significantly higher degrees of symptom-
atology prior to admission. Also, their access to inpatient
services may be less streamlined than that of patients
followed-up in an assertive intervention, where staff often
facilitates admissions directly. This would contribute to
the mean duration of stay which has been shown to be
significantly longer in controls than in the intervention
group. Another contributing factor in this regard, may
be the fact that the particular inpatient units these pa-
tients had access to are continuously under significant
pressure, with a crisis discharge policy often prompting
early discharges to create beds for patient who are more
ill. However, it is likely that patients who are followed-up
by an intervention service may be less likely to be dis-
charged early, since their key workers may intervene on
their behalf and request that they be optimally stabilized.
It is important to note that the intervention group still
had 18 readmissions. Keeping in mind that all patients
met a HFU criteria at inclusion, it is inevitable that some
patients will require readmission no matter how effective
and comprehensive the intervention is and that the aim
is not to avoid readmission at all cost. In fact, in some
cases, a readmission may provide a necessary time-outfor both patient and staff to revisit the treatment plan
and refine the therapeutic relationship.
Though a number of recent international publications
have raised serious doubts about the future of ACT teams,
the approach has provided a large body of research evidence
and has been vital in the development of new services [1].
While the evidence clearly indicates that benefits may
be limited and cost unjustifiable in settings where
standard care services are well-resourced and able to
provide comprehensive care, the contrary may be true
in under-resourced areas. In fact, our results indicate
that even modified versions of the original approach,
with significantly larger caseloads and less frequent
visits, can successfully reduce inpatient usage in high
frequency patients. Once again, this may reflect more on
the nature of standard care than the efficacy of the inter-
vention. Certainly there is the hope that even in under-
resourced settings an approach such as this will influence
the way standard care is delivered and that over time some
of the salient features of the intervention will be incorpo-
rated into standard care practice, as has been the case in
other settings.
Conclusion
Assertive interventions can successfully be modified in
under-resourced settings and sustain reductions in in-
patient usage over time, while still remaining afford-
able and feasible within the context of a developing
country. Such interventions need not be exclusive and
limited to a small number of patients but can be suc-
cessfully incorporated into existing services and tai-
lored according to the needs of the community and
resources available.
Limitations
Single-site studies on the effectiveness of ACT tend to
have small sample sizes (range 41 to 64) [6,7,11]. The
reason for this may vary from country to country, but in
a developing country such as RSA, limited human and
financial resources are the main drivers behind this. Our
sample size was limited by the small ACT team size and
the limitation on caseloads (n = 80 per team member).
Despite the small sample size, we were still able to dem-
onstrate a clear advantage for ACT in terms of time to
first admission and total number of re-admissions over
the observation period. These findings are based on a
per-protocol statistical analysis and thus only include pa-
tients who completed the treatment originally allocated.
One could argue that the sample size would have been
increased by including a more diverse diagnostic group.
The disadvantage of such an approach is that the likeli-
hood of unbalanced groups (in terms of diagnostic cat-
egories) will increase significantly and thus require
significantly larger samples and resources. It is thus
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diagnostic generalizability.
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